Genomic Biomarkers Market
Genomic Biomarkers Market - Global Industry Assessment & Forecast
#
Pages:
148
Base Year:
2022
Aug - 2023
Format:
Report Code:
VMR-2234
Segments Covered
By
Type Predictive Biomarkers, Prognostic Biomarkers
-
By
Disease Indication Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
-
By
Validation Analytical Validation, Clinical Validation, Clinical Utility
-
By
End User Hospitals, Diagnostic Centers, Research Laboratories, Other End Users
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 3.7 Billion |
 Revenue 2030:
|
USD 8.6 Billion |
 Revenue CAGR
(2023 - 2030): |
12.9% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Genomic Biomarkers Market Segment Analysis
- Genomic Biomarkers Type Outlook (Revenue, USD Million, 2018 - 2030)
- Predictive Biomarkers
- Prognostic Biomarkers
- Genomic Biomarkers Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Genomic Biomarkers Validation Outlook (Revenue, USD Million, 2018 - 2030)
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Genomic Biomarkers End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
-
North America Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
-
North America Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
-
North America Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- U.S.
- U.S. Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- U.S. Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- U.S. Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- U.S. Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- U.S. Genomic Biomarkers Market, by Type
- Canada
- Canada Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Canada Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Canada Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Canada Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Canada Genomic Biomarkers Market, by Type
-
Mexico
- Mexico Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Mexico Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Mexico Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Mexico Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Mexico Genomic Biomarkers Market, by Type
-
North America Genomic Biomarkers Market, by Type
- Europe
-
Europe Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
-
Europe Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
-
Europe Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
-
Europe Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- U. K.
- U.K. Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- U.K. Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- U.K. Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- U.K. Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- U.K. Genomic Biomarkers Market, by Type
- France
- France Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- France Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- France Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- France Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- France Genomic Biomarkers Market, by Type
-
Germany
- Germany Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Germany Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Germany Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Germany Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Germany Genomic Biomarkers Market, by Type
-
Italy
- Italy Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Italy Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Italy Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Italy Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Italy Genomic Biomarkers Market, by Type
-
Spain
- Spain Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Spain Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Spain Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Spain Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Spain Genomic Biomarkers Market, by Type
-
Rest of Europe
- Rest of Europe Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Rest of Europe Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Rest of Europe Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Rest of Europe Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Rest of Europe Genomic Biomarkers Market, by Type
-
Europe Genomic Biomarkers Market, by Type
- Asia Pacific
-
Asia Pacific Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
-
Asia Pacific Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
-
Asia Pacific Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
-
Asia Pacific Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- China
- China Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- China Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- China Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- China Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- China Genomic Biomarkers Market, by Type
- Japan
- Japan Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Japan Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Japan Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Japan Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Japan Genomic Biomarkers Market, by Type
-
Germany
- Germany Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Germany Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Germany Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Germany Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Germany Genomic Biomarkers Market, by Type
-
India
- India Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- India Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- India Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- India Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- India Genomic Biomarkers Market, by Type
-
South Korea
- South Korea Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- South Korea Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- South Korea Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- South Korea Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- South Korea Genomic Biomarkers Market, by Type
-
South East Asia
- South East Asia Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- South East Asia Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- South East Asia Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- South East Asia Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- South East Asia Genomic Biomarkers Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Rest of Asia Pacific Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Rest of Asia Pacific Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Rest of Asia Pacific Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Rest of Asia Pacific Genomic Biomarkers Market, by Type
-
Asia Pacific Genomic Biomarkers Market, by Type
- Latin America
-
Latin America Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
-
Latin America Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
-
Latin America Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
-
Latin America Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Brazil
- Brazil Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Brazil Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Brazil Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Brazil Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Brazil Genomic Biomarkers Market, by Type
- Argentina
- Argentina Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Argentina Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Argentina Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Argentina Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Argentina Genomic Biomarkers Market, by Type
-
Rest of Latin America
- Rest of Latin America Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Rest of Latin America Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Rest of Latin America Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Rest of Latin America Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Rest of Latin America Genomic Biomarkers Market, by Type
-
Latin America Genomic Biomarkers Market, by Type
- Middle East & Africa
-
Middle East & Africa Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
-
Middle East & Africa Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
-
Middle East & Africa Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
-
Middle East & Africa Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- GCC Countries
- GCC Countries Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- GCC Countries Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- GCC Countries Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- GCC Countries Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- GCC Countries Genomic Biomarkers Market, by Type
- South Africa
- South Africa Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- South Africa Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- South Africa Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- South Africa Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- South Africa Genomic Biomarkers Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Genomic Biomarkers Market, by Type
- Predictive Biomarkers
- Prognostic Biomarkers
- Rest of Middle East & Africa Genomic Biomarkers Market, by Disease Indication
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Renal Disorders
- Other Disease Indications
- Rest of Middle East & Africa Genomic Biomarkers Market, by Validation
- Analytical Validation
- Clinical Validation
- Clinical Utility
- Rest of Middle East & Africa Genomic Biomarkers Market, by End User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Other End Users
- Rest of Middle East & Africa Genomic Biomarkers Market, by Type
-
Middle East & Africa Genomic Biomarkers Market, by Type
- North America
Vantage Market
Research | 10-Aug-2023
FAQ
Frequently Asked Question
What is the global demand for Genomic Biomarkers in terms of revenue?
-
The global Genomic Biomarkers valued at USD 3.7 Billion in 2022 and is expected to reach USD 8.6 Billion in 2030 growing at a CAGR of 12.9%.
Which are the prominent players in the market?
-
The prominent players in the market are Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), QIAGEN (Germany), Bio-Rad Laboratories Inc. (U.S.), Myriad Genetics Inc. (U.S.), Eurofins Scientific (Luxembourg), Almac Group (UK), Agilent (U.S.), Illumina (U.S.), Pfizer Inc. (U.S.), Danaher Corp. (U.S.), Siemens Healthineers AG (Germany), Merck KGaA (Germany).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.9% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Genomic Biomarkers include
- Rise in demand for personalized medicine will propel the market growth
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Genomic Biomarkers in 2022.
